Trial Profile
Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2020
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary) ; Norethisterone
- Indications Pain
- Focus Therapeutic Use
- 23 Oct 2018 Status changed from recruiting to completed.
- 01 May 2018 Planned End Date changed from 1 Mar 2018 to 1 Sep 2018.
- 01 May 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2018.